Showing results (631-640 of 1,919) with videos related to

Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|September 19, 2018
Ubiquitin-specific protease 22 promotes the proliferation, migration and invasion of glioma cellsJun Liang, Xian-Li Zhang, Shun Li, et al.
Cancer Biomarkers : Section a of Disease Markers|May 20, 2019
Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinomaAris I Giotakis, Andreas C Lazaris, Agapi Kataki, et al.
Cancer Biomarkers : Section a of Disease Markers|May 20, 2019
Detection of serum protein and circulating mRNA of cMET, HGF EGF and EGFR levels in lung cancer patients to guide individualized therapyMurat Serilmez, Emre Özgür, Sule Karaman, et al.
Cancer Biomarkers : Section a of Disease Markers|November 27, 2018
α2δ1 may be a potential marker for cancer stem cell in laryngeal squamous cell carcinomaChaoping Huang, Yan Li, Wei Zhao, et al.
Cancer Biomarkers : Section a of Disease Markers|November 27, 2018
Association between genetic polymorphisms in long non-coding RNAs and pancreatic cancer riskD Moschovis, E Vasilaki, M Tzouvala, et al.
Cancer Biomarkers : Section a of Disease Markers|October 29, 2019
Preoperative C-reactive protein-to-albumin ratio predicts anastomotic leak in elderly patients after curative colorectal surgeryYongming Yu, Zhou Wu, Zhonglei Shen, et al.
Cancer Biomarkers : Section a of Disease Markers|December 17, 2019
Evaluation of a panel of tumor-associated antigens in breast cancerCecilia Pagaza-Straffon, Laurence A Marchat, Luis Herrera, et al.
Cancer Biomarkers : Section a of Disease Markers|January 21, 2020
Circulating Epstein-Barr virus microRNA profile reveals novel biomarker for nasopharyngeal carcinoma diagnosisLirong Wu, Jingyi Wang, Danxia Zhu, et al.
Cancer Biomarkers : Section a of Disease Markers|January 21, 2020
Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencingHongyun Ma, Bin Song, Shiwei Guo, et al.
Cancer Biomarkers : Section a of Disease Markers|January 21, 2020
METCAM/MUC18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: Validation with Western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassayYuan-Hung Pong, Yann-Rong Su, Hsing-Wen Lo, et al.
Pageof 192